Blockmans discussed data supporting upadacitinib’s new indication and why the approval is important for patients with giant cell arteritis.
Daniel Blockmans, MD, PhD
Advertisement
Articles by Daniel Blockmans, MD, PhD
Advertisement
Latest Updated Articles
Adding Upadacitinib to the Treatment Landscape of GCA, with Daniel Blockmans, MD, PhDPublished: May 7th 2025 | Updated:
Advertisement
Advertisement